PTHrP analogue

0 marketed 2 in Phase 2

This page covers all PTHrP analogue drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting PTHrP.

Targets

Phase 2 pipeline (2)

Cohort 2 CTAP101 Capsules - 30µg · OPKO Health, Inc. · Bone disorders
CTAP101 is a recombinant human parathyroid hormone-related protein (PTHrP) analogue.
Cohort 1 CTAP101 Capsules - 90µg · OPKO Health, Inc. · Osteoporosis
CTAP101 is a recombinant human parathyroid hormone-related protein (PTHrP) analogue.